Cryptogenic Subtype Predicts Reduced Survival Among Cancer Patients With Ischemic Stroke
- 1 August 2014
- journal article
- research article
- Published by Wolters Kluwer Health in Stroke
- Vol. 45 (8) , 2292-2297
Abstract
Background and Purpose—: Cryptogenic stroke is common in patients with cancer. Autopsy studies suggest that many of these cases may be because of marantic endocarditis, which is closely linked to cancer activity. We, therefore, hypothesized that among patients with cancer and ischemic stroke, those with cryptogenic stroke would have shorter survival. Methods—: We retrospectively analyzed all adult patients with active systemic cancer diagnosed with acute ischemic stroke at a tertiary care cancer center from 2005 through 2009. Two neurologists determined stroke mechanisms by consensus. Patients were diagnosed with cryptogenic stroke if no specific mechanism could be determined. The diagnosis of marantic endocarditis was restricted to patients with cardiac vegetations on echocardiography or autopsy and negative blood cultures. Patients were followed until July 31, 2012, for the primary outcome of death. Kaplan–Meier statistics and the log-rank test were used to compare survival between patients with cryptogenic stroke and patients with known stroke mechanisms. Multivariate Cox proportional hazard analysis evaluated the association between cryptogenic stroke and death after adjusting for potential confounders. Results—: Among 263 patients with cancer and ischemic stroke, 133 (51%) were cryptogenic. Median survival in patients with cryptogenic stroke was 55 days (interquartile range, 21–240) versus 147 days (interquartile range, 33–735) in patients with known stroke mechanisms ( P <0.01). Cryptogenic stroke was independently associated with death (hazard ratio, 1.64; 95% confidence interval, 1.25–2.14) after adjusting for age, systemic metastases, adenocarcinoma histology, and functional status. Conclusions—: Cryptogenic stroke is independently associated with reduced survival in patients with active cancer and ischemic stroke.Keywords
This publication has 25 references indexed in Scilit:
- Stroke and CancerStroke, 2012
- Coagulopathy and embolic signal in cancer patients with ischemic strokeAnnals of Neurology, 2010
- Ischemic Stroke in Cancer Patients With and Without Conventional MechanismsStroke, 2010
- Intracerebral and subarachnoid hemorrhage in patients with cancerNeurology, 2010
- Yield of Transesophageal Echocardiography for Nonbacterial Thrombotic Endocarditis and Other Cardiac Sources of Embolism in Cancer Patients With Cerebral IschemiaThe American Journal of Cardiology, 2006
- Medical Record Reviews in Emergency Medicine: The Blessing and the CurseAnnals of Emergency Medicine, 2005
- Poor Outcome After First-Ever StrokeStroke, 2003
- Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.Stroke, 1993
- Interobserver agreement for the assessment of handicap in stroke patients.Stroke, 1988
- Cerebrovascular Complications in Patients with CancerMedicine, 1985